Fulgent Sees FY23 Core Revenue $260M Vs $260.66M Estimate, Adj. EPS $(0.95) Vs $(1.09) Estimate
Portfolio Pulse from Benzinga Newsdesk
Fulgent Genetics (FLGT) has projected its FY23 core revenue to be $260M, slightly below the estimated $260.66M. The company also expects its adjusted EPS to be $(0.95), better than the estimated $(1.09).
November 03, 2023 | 11:27 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Fulgent Genetics' FY23 core revenue projection is slightly below estimates, but its adjusted EPS is expected to outperform. This mixed outlook may lead to uncertain market reactions.
Fulgent Genetics' lower-than-expected revenue projection could negatively impact its stock price. However, the better-than-expected EPS could offset this, leading to a neutral score. The news is highly relevant as it directly pertains to the company's financial outlook.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100